Aorta-to-Left Atrial Fistula Developing After Surgical Removal of an Atrial Septal Occlusion Device Eight Years After Original Implantation-Reference-Cited by-同舟云学术

Aorta-to-Left Atrial Fistula Developing After Surgical Removal of an Atrial Septal Occlusion Device Eight Years After Original Implantation

Published:2015-04 Issue:2 Volume:6 Page:320-323
ISSN:2150-1351
Container-title:World Journal for Pediatric and Congenital Heart Surgery
language:en
Short-container-title:World J Pediatr Congenit Heart Surg

Author:

Beg Kisha¹,Latson Larry A.²,Pettersson Gosta³,Wallace Lee⁴,Qureshi Athar M.⁵

Affiliation:

1. Aga Khan University Medical College, Karachi, Pakistan

2. Department of Cardiology, Joe DiMaggio Children’s Hospital, Hollywood, FL, USA

3. Department of Thoracic and Cardiovascular Surgery, The Cleveland Clinic, Cleveland, OH, USA

4. Department of Cardiothoracic Anesthesiology, The Cleveland Clinic, Cleveland, OH, USA

5. Department of Cardiology, Texas Children’s Hospital/Baylor College of Medicine, Houston, TX, USA

Abstract

Cardiac erosions may occur in a small percentage of patients after device closure of atrial septal defects. These devices have to be explanted. We report an aorta-to-left atrial fistula after surgical explantation of the device eight years after implant for access to mitral valve repair. The importance of realizing the risk of subclinical cardiac erosion and subsequent fistula development after device removal is discussed.

Publisher

SAGE Publications

Subject

Cardiology and Cardiovascular Medicine,General Medicine,Pediatrics, Perinatology and Child Health,Surgery

Link

http://journals.sagepub.com/doi/pdf/10.1177/2150135114561688

Reference7 articles.

1. Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults

2. Results of the U.S. Multicenter Pivotal Study of the HELEX Septal Occluder for Percutaneous Closure of Secundum Atrial Septal Defects

3. Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: Review of registry of complications and recommendations to minimize future risk

4. Analysis of the US Food and Drug Administration Manufacturer and User Facility Device Experience database for adverse events involving Amplatzer septal occluder devices and comparison with the Society of Thoracic Surgery congenital cardiac surgery database

5. Erosion by the amplatzer septal occluder: Experienced operator opinions at odds with manufacturer recommendations?

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Device closure of secundum atrial septal defect's and the risk of cardiac erosion;Echo Research and Practice;2015-09